Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Neu5Gc antibody

This anti- antibody is a Chicken Polyclonal antibody detecting in FACS. Suitable for Mammalian.
Catalog No. ABIN2656682

Quick Overview for Neu5Gc antibody (ABIN2656682)

Target

Neu5Gc

Reactivity

Mammalian

Host

Chicken

Clonality

Polyclonal

Application

Flow Cytometry (FACS)

Clone

Poly21469
  • Cross-Reactivity (Details)

    All mammals except human

    Isotype

    IgY
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid, Lyophilized

    Buffer

    This Neu5Gc antibody is lyophilized.

    Storage

    -20 °C

    Storage Comment

    For long-term storage, store the lyophilized antibody at -20°C or -70°C. After reconstitution, store the antibody between 2°C and 8°C for up to 2 weeks. For longer term storage up to 6 months, store the reconstituted product in aliquots at -20°C.
  • Target

    Neu5Gc

    Background

    Neu5Gc (N-Glycolylneuraminic acid) is a sialic acid molecule found in most mammals but not in humans. It is derived from the most commonly expressed sialic acid, Neu5Ac, differing from it by only one oxygen atom. The gene CMAH that encodes for CMP-N-acetylneuraminic acid hydroxylase is responsible for the conversion of Neu5Ac to Neu5Gc. In humans, this gene is inactive due to a deletion mutation. As such, the human immune system sees Neu5Gc as a foreign, immunogenic molecule. Neu5Gc enters the human body primarily through dietary intake of red meat and dairy products. Neu5Gc is also incorporated, albeit to a lesser degree, into certain biopharmaceuticals, through the use of animal-derived reagents and cell lines during the manufacturing of these products. Due to its immunogenic properties, the intake and incorporation of Neu5Gc in humans causes the formation of circulating antibodies against this non-human molecule, which can lead to chronic inflammation, the exacerbation of certain diseases, and possibly reduced the efficacy of biopharmaceuticals.
You are here:
Chat with us!